Volunteers participating in trials of a coronavirus vaccine developed by the Russian Defense Ministry in conjunction with the Gamalei National Research Center for Epidemiology and Microbiology have no complications or adverse reactions.
the press service of the Ministry of Defense reports.
"After two weeks from the date of vaccination, the health status of participants in the coronavirus vaccine trials... is stable, no complications or adverse reactions," the statement said.
All volunteers are under constant dynamic supervision of medical specialists-they regularly measure their blood pressure, pulse, temperature, conduct auscultation and laboratory tests "to study the intensity of the humoral immune response", as well as examine the site of the injection.
Next week, on the 21st day after the first vaccination, the second group of volunteers will be injected with the second component of the vaccine to strengthen the body's protective functions and increase the duration of immunity.
Earlier, Russian Defense Minister Sergey Shoigu reported to Russian leader Vladimir Putin that research on the COVID-19 vaccine would be completed at the end of July.
GSV "Russia - Islamic World"
Photo: Chokniti Khongchum / Pixabay
Based on materials from RT